Clinical Trial Update: Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer [Phase 3]

View source ↗

Summary

An extension study assessing the long-term safety of denosumab in patients undergoing androgen deprivation therapy for non-metastatic prostate cancer; completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Non-metastatic Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Amgen | Conditions: Cancer, Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2013-09-24